Pfizer has a pipeline with more than 90 drugs in development. Pfizer is developing two drugs capable of generating more than a billion sales. Competition is fierce but Pfizer is in the race.
New product candidates aim to diversify into areas with a large unmet medical need.
Healthcare services provider Zuellig Pharma Corp. is expanding its facilities and beefing up its digital solutions in the country to serve increasing demand.
Value Investing | Market insights and news of the investment gurus. Value investing screens and valuation tools.
The week in pharma: action, reaction and insight – week to July 1 2022
Moderna, Inc. (NASDAQ:MRNA – Get Rating) Director Noubar Afeyan sold 10,000 shares of the stock in a transaction dated Wednesday, June 29th. The stock was sold at an average price of $140.47, for a total value of $1,404,700.00. Following the sale, the director now directly owns 2,517,209 shares in t…
Moderna, Inc. (NASDAQ:MRNA - Get Rating) Director Noubar Afeyan sold 10,000 shares of the business’s stock in a transaction on Wednesday, June 29th. The stock was sold at an average price of $140.47, for a total value of $1,404,700.00. Following the completion of the transaction, the director now di…
Ellevest Inc. grew its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Get Rating) by 47.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 743 shares of the company’s stock after acquiring an additional…
Influenza Vaccines Market 2022 Top Key Players, Demands, Trends and Forecasts to 2030 – Indian Defence News Indian Defence News
Proponents for a waiver on intellectual property (IP) rights on Covid-19 vaccines and drugs are disappointed.
Check out these health care stocks this holiday-shortened week.
Researchers at Hannover Medical School have gained new insights into the cytokine meteorin-like (METRNL) and its role in promoting heart repair after myocardial infarction.
Metastatic Castration-Sensitive Prostate Cancer market dynamics is anticipated to witness a significant growth owing to the rising prevalence of prostate cancer cases due to the rapidly aging population growing awareness
Monkeypox is unlikely to become a global pandemic like COVID-19, but vaccine manufacturers are expanding their programs, just in case. Currently, there are two approved smallpox vaccines (which offer protection against monkeypox) in the U.S.--ACAM2000 (Sanofi Pasteur Biologics) and Bavarian Nordic’s…
A preview of the next edition of BioWorld, June 20, 2022
Genmab and AbbVie announce positive data in large b-cell lymphoma, Intra-Cellular’s bipolar depression candidate hits the endpoint in Phase III and more.
Global Chikungunya Fever Drugs Market Research by Business Analysis, 2022-2030 – Indian Defence News Indian Defence News
Staffers from Weber Shandwick, Golin and Jack Health are contributing to the Dxtra team, which is working on corporate communications and promotion of Moderna’s mRNA technology.
Three scientists whose research laid the foundation for messenger RNA (mRNA) COVID-19 vaccines were named the winners of the 2022 Tang Prize in Biopharmaceutical Science at a ceremony in Taipei yesterday. Katalin Kariko, Drew Weissman and Pieter Cullis were recognized “for the discovery of key vacci…
Moderna, Inc. (NASDAQ:MRNA - Get Rating) Director Noubar Afeyan sold 10,000 shares of the stock in a transaction on Wednesday, June 8th. The shares were sold at an average price of $147.47, for a total value of $1,474,700.00. Following the completion of the sale, the director now owns 2,537,209 shar…